CN116410871A - Fusarium equisetum and method for hydroxylating cholic acid by using same - Google Patents
Fusarium equisetum and method for hydroxylating cholic acid by using same Download PDFInfo
- Publication number
- CN116410871A CN116410871A CN202310241202.4A CN202310241202A CN116410871A CN 116410871 A CN116410871 A CN 116410871A CN 202310241202 A CN202310241202 A CN 202310241202A CN 116410871 A CN116410871 A CN 116410871A
- Authority
- CN
- China
- Prior art keywords
- fusarium
- culture
- medium
- equisetum
- fusarium equiseti
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000879295 Fusarium equiseti Species 0.000 title claims abstract description 75
- 238000000034 method Methods 0.000 title claims abstract description 28
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 title claims abstract description 11
- 239000004380 Cholic acid Substances 0.000 title claims abstract description 11
- 229960002471 cholic acid Drugs 0.000 title claims abstract description 11
- 235000019416 cholic acid Nutrition 0.000 title claims abstract description 11
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 title claims abstract description 11
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 title claims abstract description 10
- 230000000640 hydroxylating effect Effects 0.000 title abstract description 4
- 238000000855 fermentation Methods 0.000 claims abstract description 31
- 230000004151 fermentation Effects 0.000 claims abstract description 31
- SMEROWZSTRWXGI-UHFFFAOYSA-N Lithocholsaeure Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)CC2 SMEROWZSTRWXGI-UHFFFAOYSA-N 0.000 claims abstract description 24
- RUDATBOHQWOJDD-UHFFFAOYSA-N (3beta,5beta,7alpha)-3,7-Dihydroxycholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)CC2 RUDATBOHQWOJDD-UHFFFAOYSA-N 0.000 claims abstract description 22
- SMEROWZSTRWXGI-HVATVPOCSA-N lithocholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 SMEROWZSTRWXGI-HVATVPOCSA-N 0.000 claims abstract description 22
- RUDATBOHQWOJDD-UZVSRGJWSA-N ursodeoxycholic acid Chemical compound C([C@H]1C[C@@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 RUDATBOHQWOJDD-UZVSRGJWSA-N 0.000 claims abstract description 21
- 229960001661 ursodiol Drugs 0.000 claims abstract description 16
- 238000004321 preservation Methods 0.000 claims abstract description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 46
- 239000002609 medium Substances 0.000 claims description 34
- 229910052757 nitrogen Inorganic materials 0.000 claims description 23
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 22
- 229910052799 carbon Inorganic materials 0.000 claims description 22
- 239000000843 powder Substances 0.000 claims description 20
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 16
- 239000001963 growth medium Substances 0.000 claims description 16
- 230000001954 sterilising effect Effects 0.000 claims description 12
- 239000000725 suspension Substances 0.000 claims description 11
- 238000009630 liquid culture Methods 0.000 claims description 10
- 238000011218 seed culture Methods 0.000 claims description 10
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims description 8
- 229910021645 metal ion Inorganic materials 0.000 claims description 7
- 229920001353 Dextrin Polymers 0.000 claims description 6
- 239000004375 Dextrin Substances 0.000 claims description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 6
- 239000001888 Peptone Substances 0.000 claims description 6
- 108010080698 Peptones Proteins 0.000 claims description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 6
- 235000019425 dextrin Nutrition 0.000 claims description 6
- 239000008103 glucose Substances 0.000 claims description 6
- 235000019319 peptone Nutrition 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 5
- 239000007787 solid Substances 0.000 claims description 5
- 238000004659 sterilization and disinfection Methods 0.000 claims description 5
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 4
- 229920002472 Starch Polymers 0.000 claims description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 4
- 229930006000 Sucrose Natural products 0.000 claims description 4
- 240000008042 Zea mays Species 0.000 claims description 4
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 4
- 229960001230 asparagine Drugs 0.000 claims description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 4
- 235000005822 corn Nutrition 0.000 claims description 4
- 239000002054 inoculum Substances 0.000 claims description 4
- 239000008101 lactose Substances 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 239000008107 starch Substances 0.000 claims description 4
- 235000019698 starch Nutrition 0.000 claims description 4
- 239000005720 sucrose Substances 0.000 claims description 4
- 229910021591 Copper(I) chloride Inorganic materials 0.000 claims description 3
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 3
- 229920000053 polysorbate 80 Polymers 0.000 claims description 3
- 239000011780 sodium chloride Substances 0.000 claims description 3
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 claims description 2
- 229920001817 Agar Polymers 0.000 claims description 2
- 241000223218 Fusarium Species 0.000 claims description 2
- 244000061456 Solanum tuberosum Species 0.000 claims description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 2
- 239000008272 agar Substances 0.000 claims description 2
- 238000012258 culturing Methods 0.000 claims description 2
- 238000011534 incubation Methods 0.000 claims description 2
- 238000011081 inoculation Methods 0.000 claims description 2
- 239000011550 stock solution Substances 0.000 claims description 2
- 238000006243 chemical reaction Methods 0.000 abstract description 18
- 230000000813 microbial effect Effects 0.000 abstract description 6
- 239000000758 substrate Substances 0.000 abstract description 5
- 230000000694 effects Effects 0.000 description 10
- 230000012010 growth Effects 0.000 description 10
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 210000000941 bile Anatomy 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000008223 sterile water Substances 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 2
- 101000597041 Gallus gallus Transcriptional enhancer factor TEF-3 Proteins 0.000 description 2
- 101000653735 Homo sapiens Transcriptional enhancer factor TEF-1 Proteins 0.000 description 2
- 102000008109 Mixed Function Oxygenases Human genes 0.000 description 2
- 108010074633 Mixed Function Oxygenases Proteins 0.000 description 2
- 102100029898 Transcriptional enhancer factor TEF-1 Human genes 0.000 description 2
- 230000003698 anagen phase Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 239000005515 coenzyme Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 208000001130 gallstones Diseases 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- -1 hydroxyl cholic acid Chemical compound 0.000 description 2
- 125000003219 lithocholic acid group Chemical group 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 238000011426 transformation method Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- 206010008635 Cholestasis Diseases 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 208000022873 Ocular disease Diseases 0.000 description 1
- 206010057969 Reflux gastritis Diseases 0.000 description 1
- 241001052560 Thallis Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- WXYIONYJZVWSIJ-UHFFFAOYSA-N acetonitrile;methanol;hydrate Chemical compound O.OC.CC#N WXYIONYJZVWSIJ-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 210000000013 bile duct Anatomy 0.000 description 1
- 230000002210 biocatalytic effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- RUDATBOHQWOJDD-BSWAIDMHSA-N chenodeoxycholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 RUDATBOHQWOJDD-BSWAIDMHSA-N 0.000 description 1
- 229960001091 chenodeoxycholic acid Drugs 0.000 description 1
- 208000003167 cholangitis Diseases 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 150000001840 cholesterol esters Chemical class 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- FMGSKLZLMKYGDP-USOAJAOKSA-N dehydroepiandrosterone Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC=C21 FMGSKLZLMKYGDP-USOAJAOKSA-N 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000005805 hydroxylation reaction Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 229960002847 prasterone Drugs 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/145—Fungal isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P33/00—Preparation of steroids
- C12P33/06—Hydroxylating
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
- C12R2001/77—Fusarium
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Botany (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The invention belongs to the technical field of biology, and relates to a Fusarium equisetum (Fusarium equiseti) and a method for hydroxylating cholic acid by using the same. The Fusarium equisetum is Fusarium equisetum (Fusarium equiseti) HG18, and the preservation number is CCTCC M2023160. By adopting the microbial fermentation method, the conversion rate of ursodeoxycholic acid reaches 42% at the substrate concentration of 2g/L of lithocholic acid.
Description
Technical Field
The invention belongs to the technical field of biology, and particularly relates to a method for preparing hydroxyl cholic acid from Fusarium equisetum (Fusarium equiseti).
Background
Ursodeoxycholic acid (Ursodeoxycholic Acid, UDCA), also known as 3 alpha, 7 beta-dihydroxyl-5 beta-cholestane-24-acid, is a hydrophilic bile acid with various biological activities, is also a main active ingredient of traditional rare traditional Chinese medicine bear gall powder, can increase secretion of bile, inhibit cytotoxicity of hydrophobic cholic acid, protect bile duct cells and liver cells from toxic bile injury, has extremely strong function of promoting fat and fatty acid hydrolysis, reduces cholesterol and cholesterol ester in bile, is favorable for gradually dissolving cholesterol in gall stone, and is mainly used for treating various liver and gall diseases and digestive tract diseases clinically, such as treating gall stone, cholestatic liver disease, fatty liver, various hepatitis, toxic liver disorder, cholecystitis, cholangitis, bile dyspepsia, bile reflux gastritis, ocular disease and the like.
The existing ursodeoxycholic acid preparation methods generally comprise the following steps, namely, the method is obtained through bear bile extraction, and the method is gradually eliminated due to limited sources or animal protection laws; secondly, animal cholic acid substances such as cholic acid, chenodeoxycholic acid and the like are used as raw materials to be prepared by chemical or biological synthesis methods, and the methods have the problems of limited raw material sources, long reaction steps, low yield and the like (X.L.He, L.T.Wang, X.Z.Gu, J.X.Xiao, W.W.Qiu, steroids,2018,140:173-178;M.M.Zheng,R.F.Wang,C.X.Li,J.H.Xu,Process Biochemistry,2015,50:598-604); thirdly, a synthetic method which takes plant-derived dehydroandrosterone as a raw material prepares ursodeoxycholic acid (W.Chen, D.Hu, Z.Feng, Z.Liu, steroids,2021, 172:10887.) through eight steps of reactions, and the method belongs to a method for preparing the raw material of non-animal cholic acid, but the separation, purification and separation amount of plants are very large problems; fourth, it is prepared by an enzymatic method, and chinese patent CN109154016a reports that lithocholic acid undergoes hydroxylation reaction under the catalytic action of hydroxylase and coenzyme to obtain ursodeoxycholic acid. The coenzyme is needed in the reaction, the cost is high, and in addition, the hydroxylase of the technology is obtained by separating from thalli, the steps are complex, the cost is high, and the technology is only suitable for experimental stage research and is difficult to realize industrialized application.
Disclosure of Invention
One of the technical problems to be solved by the invention is to provide the fusarium equiseti (Fusarium equiseti) which has the function of catalyzing and converting the lithocholic acid into ursodeoxycholic acid.
One of the technical problems to be solved by the invention is to provide a method for preparing ursodeoxycholic acid by microbial fermentation, which has higher reaction yield.
In order to achieve the above purpose, the invention obtains a microorganism strain HG18 through screening, and the microorganism strain is identified as Fusarium equisetum (Fusarium equiseti) (see figure 1), and is preserved in the China center for type culture collection (preservation number CCTCC M2023160) of No. 299 in Wuchang district of Wuhan, hubei province for 20 days in 2023. The strain can take lithocholic acid as a substrate, introduce beta-configuration hydroxyl into the 7-position of the lithocholic acid by a microbial transformation method, and obtain ursodeoxycholic acid after simple treatment. The method has the advantages of low cost, simple process, mild reaction conditions, simple and easily obtained reagent and suitability for industrialized mass production.
The equation for the above reaction is as follows:
the aim of the invention is realized by the following technical scheme:
the first aim of the invention is to provide Fusarium equisetum (Fusarium equiseti) HG18 with a preservation number of CCTCC M2023160.
Another object of the present invention is to provide a method for hydroxylating cholic acid using the above fusarium equiseti, comprising the steps of:
adding a liquid culture containing Fusarium equisetosum into a fermentation medium, adding lithocholic acid, and culturing to obtain a fermentation broth containing ursodeoxycholic acid;
the Fusarium equisetum is Fusarium equisetum (Fusarium equiseti) HG18 CCTCC M2023160.
Preferably, the fermentation medium is composed of: 20-30g/L of carbon source, 10-30g/L of nitrogen source, 1-5g/L of yeast powder and KH 2 PO 4 1-5g/L,MgSO 4 ·7H 2 O 0.1-1g/L,FeSO 4 ·7H 2 0.01-0.5g/L O, 0-0.1M metal ion compound; adjusting pH of the culture medium to 5.5-10 before sterilization, and sterilizing at 121+ -5deg.C under high pressure steam for 20+ -5 min.
More preferably, the composition of the fermentation medium is as follows: 20g/L of carbon source, 15g/L of nitrogen source, 1g/L of yeast powder and KH 2 PO 4 3g/L,MgSO 4 ·7H 2 O 0.5g/L,FeSO 4 ·7H 2 O0.02 g/L; the pH of the medium was adjusted to 7.5 before sterilization.
Preferably, the carbon source is one or more than two of glucose, lactose, sucrose, soluble starch and dextrin;
the nitrogen source is NH 4 One or more of Cl, corn steep liquor dry powder, wall-broken dry yeast, peptone, yeast powder and L-asparagine;
the metal ion compound is NaCl, caCl 2 、MgCl 2 、CuCl 2 、ZnCl 2 、NH 4 One or more of Cl and KCl.
Preferably, the inoculum size of Fusarium equisetum is 10-30% (v/v), and the final concentration of lithocholic acid in the fermentation medium is 2g/L; the culture conditions were as follows: the culture temperature is 25-30 ℃, and the fermentation culture is carried out for 96-144h at the rotating speed of 120-220 rpm.
Preferably, the liquid culture containing fusarium equiseti is obtained by the following steps: 100 mu L of fusarium equiseti spore frozen stock solution is coated on a PDA solid culture medium, cultured for 5-7 days at 25-40 ℃, resuspended by 0.2% Tween 80 water to obtain spore suspension, and inoculated into a seed culture medium for culture, thus obtaining the fusarium equiseti-containing liquid culture.
Preferably, the concentration of spores in the spore suspension is (1-1.7). Times.10 6 The spore/mL is inoculated into 50mL of seed culture medium at the inoculation proportion of 1mL spore suspension, and the culture condition is that the temperature is 25-30 ℃ and the culture is 120-220rpm for 12-72h.
More preferably, the seed culture medium comprises the following components in percentage by weight: 20g/L of carbon source, 15g/L of nitrogen source, 1g/L of yeast powder and KH 2 PO 4 3g/L,MgSO 4 ·7H 2 O0.5 g/L; natural pH, sterilizing at 121deg.C under high pressure steam for 20min;
the PDA culture medium comprises the following components in percentage by weight: 200g/L potato; glucose 20g/L; 20g/L of agar powder; naturally pH, and sterilizing at 121deg.C under high pressure steam for 20min.
Preferably, the carbon source of the seed culture medium is one or more than two of glucose, lactose, sucrose, soluble starch and dextrin;
the nitrogen source of the seed culture medium is NH 4 One or more of Cl, corn steep liquor dry powder, wall-broken dry yeast, peptone, yeast powder and L-asparagine;
the incubation time of the spore suspension in the seed medium was 36 hours.
Compared with the prior art, the invention has the following advantages and beneficial effects:
(1) The strain can take lithocholic acid as a substrate, introduce beta-configuration hydroxyl into the 7-position of the lithocholic acid by a microbial transformation method, and obtain ursodeoxycholic acid after simple treatment. The method has the advantages of low cost, simple process, mild reaction conditions, simple and easily obtained reagent and suitability for industrialized mass production.
(2) The method provided by the invention has higher reaction yield, and the conversion rate of ursodeoxycholic acid reaches 42% under the condition that the concentration of lithocholic acid is 2 g/L.
Drawings
FIG. 1 is a graph showing the relationship between the TEF-1 alpha region of Fusarium equisetum HG18 (Fusarium equiseti) of the present invention.
FIG. 2 is a liquid chromatogram of the reaction substrates and products of the present invention.
FIG. 3 is an optimized graph of the liquid culture of Fusarium equisetum HG18 (Fusarium equiseti) of the present invention, FIG. 3A is the effect of carbon source on Fusarium equisetum growth; FIG. 3B is an effect of nitrogen source on Fusarium equisetum growth.
FIG. 4 is a graph showing the growth of Fusarium equisetum HG18 (Fusarium equiseti) of the present invention.
FIG. 5 is an optimized diagram of fermentation medium of Fusarium equisetum HG18 (Fusarium equiseti) of the present invention, FIG. 5A is the effect of carbon source on Fusarium equisetum conversion; FIG. 5B is the effect of nitrogen source on Fusarium equisetum conversion.
FIG. 6 is a graph showing the effect of pH of the fermentation medium of the present invention on biocatalysis.
FIG. 7 is a graph showing the effect of metal ions on biocatalysis in the fermentation medium of the present invention.
FIG. 8 is a biocatalytic schedule of Fusarium equisetum HG18 (Fusarium equiseti) of the present invention.
Detailed Description
The invention is described in further detail below with reference to the drawings and examples.
Example 1 identification of Fusarium equisetum HG18 species
200mg of fresh mycelium with transformation capability obtained by screening is taken and ground into powder by liquid nitrogen, and then genomic DNA thereof is extracted by referring to a kit. After the extraction, TEF-1. Alpha. Sequence amplification was performed and the PCR amplified product was sent to Shanghai Biotechnology Co., ltd for sequencing. Sequencing results were aligned by BLAST program. And the relationship of Fusarium equisetum HG18 was mapped using MEGA11 software to determine its genus.
As shown in FIG. 1, the genus HG18 was determined to be Fusarium equisetum (Fusarium equiseti).
Example 2 detection method of reaction product (UDCA)
The substrate and the product of the reaction are detected by adopting a high performance liquid chromatography, and the detection conditions are as follows:
chromatographic column: a C18 reverse-phase chromatographic column,
mobile phase: methanol-acetonitrile-water (5:4:3, v/v) and 0.03% NaH 2 PO 4 ·2H 2 O and 0.08% H 3 PO 4 ,
Flow rate: the concentration of the solution is 0.8mL/min,
column temperature: 30 ℃,
a detector: differential refractive light detector.
The liquid chromatogram under this condition is shown in FIG. 2, with LCA retention time of 5.25 minutes and UDCA retention time of 25.75 minutes.
Example 3 preparation of Fusarium equisetum HG18 cultures
1) Preparation of Fusarium equisetum HG18 solid cultures
100. Mu.L of Fusarium equisetum spore frozen stock stored in a-80℃freezer was spread on PDA solid medium. Incubated for 5-7 days at 28℃in a biochemical incubator.
2) Optimized preparation of Fusarium equisetum HG18 liquid culture
Washing Fusarium equisetum HG18 on PDA solid medium with 10ml of 0.2% Tween 80 sterile water, gently blowing with a pipetting gun, collecting spore suspension for use, controlling the density of spore suspension to be (1-1.7). Times.10 6 spores mL -1 . 1mL of the spore suspension was then inoculated into a 250mL conical flask containing 50mL of seed medium and incubated at 28℃and 200 rpm. Different kinds of carbon sources and nitrogen sources were added to the seed medium to examine the effect of the different carbon sources and nitrogen sources on the growth of Fusarium equisetum HG 18. The optimal carbon and nitrogen source for the growth of Fusarium equisetum HG18 is determined based on the dry weight of the mycelium. As a result, as shown in FIGS. 3A and 3B, the most suitable carbon source and nitrogen source were dextrin and peptone, respectively.
The seed culture medium comprises the following components in percentage by weight: 20g/L of carbon source, 15g/L of nitrogen source, 1g/L of yeast powder and KH 2 PO 4 3g/L,MgSO 4 ·7H 2 O0.5 g/L; naturally pH, and sterilizing at 121deg.C under high pressure steam for 20min.
3) Exploration of Fusarium equisetum HG18 growth kinetics
The liquid culture is put into a centrifuge tube for repeated centrifugation and washing with clear water for three times by adopting a cell dry weight method, and then is dried in vacuum at 105 ℃ and then weighed. The growth curve of Fusarium equisetum HG18 was monitored as the dry weight of the cells. The results are shown in FIG. 4. Fusarium equisetum HG18 grew logarithmically at 24h, entered stationary phase after 72h, and then gradually declined.
4) Connection of growth period of fusarium equiseti HG18 microorganism and biocatalysis
According to the growth curve in 3), the mycelia with different growth periods are adopted for microbial catalysis, and mycelia with the optimal period are selected for the next experiment.
Mycelia grown to 12, 24, 36, 48, 60 and 72 hours were centrifuged at 6000rpm for 5min, respectively, discarded and then washed 3 times with sterile water and centrifuged at 6000rpm for 5min. Then, the sterilized fermentation medium was inoculated with an inoculum size of 10% (v/v), and an appropriate amount of lithocholic acid, which was dissolved in 1% (v/v) DMSO, was weighed, and put into the above fermentation medium so that the final concentration of lithocholic acid was 2g/L, and fermented at 28℃and 200rpm for 96 hours. The results are shown in Table 1. Therefore, mycelia grown to 36h in the early logarithmic growth phase were selected as seed cells and transferred to a transformation medium for transformation study.
TABLE 1 relationship between microbial growth phase and biocatalysis of Fusarium equisetum HG18 (Fusarium equiseti)
Example 4 Fusarium equisetum conversion of lithocholic acid (LCA) to ursodeoxycholic acid (UDCA)
1) Optimized fusarium equiseti HG18 fermentation medium
The above-mentioned liquid culture of Fusarium equisetum HG18, which had grown to a log phase of 36 hours, was centrifuged at 6000rpm for 5 minutes, then washed 3 times with sterile water and centrifuged at 6000rpm for 5 minutes, and then inoculated into a sterilized fermentation medium at an inoculum size of 10% (v/v). Different kinds of carbon sources and nitrogen sources were added to the fermentation medium to examine the effect of the different carbon sources and nitrogen sources on conversion of Fusarium equisetum HG18 into lithocholic acid. The optimal carbon source and nitrogen source for the biocatalysis of Fusarium equisetum HG18 are determined based on the yield of ursodeoxycholic acid. As a result, as shown in FIGS. 5A and 5B, the most suitable carbon source and nitrogen source were dextrin and peptone, respectively.
The pH of the fermentation medium was adjusted to 5.5, 6.5, 7.5, 8.5, 9.5, 10 at the time of formulation to examine the effect of different pH on conversion of Fusarium equisetum HG18 to lithocholic acid. The results are shown in FIG. 6, with an optimum pH of 7.5.
The components and the proportion of the fermentation medium are as follows: 20g/L of carbon source, 15g/L of nitrogen source, 1g/L of yeast powder and KH 2 PO 4 3g/L,MgSO 4 ·7H 2 O 0.5g/L,FeSO 4 ·7H 2 O0.02 g/L; the pH of the medium was adjusted to 7.5 before sterilization, and the medium was sterilized at 121℃under high pressure steam for 20min.
2) Exploration of metal ion for biocatalysis of Fusarium equisetum HG18
During the preparation of the fermentation medium, 0.1M NaCl and CaCl are added 2 、MgCl 2 、CuCl 2 、ZnCl 2 、NH 4 Cl, KCl and other metal ion compounds to examine microelementsThe effect of the pigments and inorganic salts on the biocatalysis of Fusarium equisetum. As a result, potassium ions have a promoting effect on biocatalysis as shown in FIG. 7.
3) Biocatalysis
In the optimized fermentation medium, 10% (v/v) of fusarium equiseti HG18 is inoculated, a proper amount of lithocholic acid is precisely weighed, 1% (v/v) of DMSO is used for dissolving, the lithocholic acid is added into the optimized fermentation medium to make the final concentration of the lithocholic acid be 2g/L, and the fermentation medium is cultivated for 144 hours under the conditions of 28 ℃ and 200rpm, so as to obtain a fermentation broth.
The pH of the fermentation broth obtained above was adjusted to 12 with NaOH aqueous alkali to dissolve cholic acid compounds in the fermentation broth, and then centrifuged at 12000rpm for 5min. Separating the supernatant from thallus, regulating pH of the supernatant to 2 with HCl strongly acidic aqueous solution, standing for 10min, and centrifuging at 12000rpm for 5min to obtain white precipitate as cholic acid compound. After centrifugation, most of the supernatant was discarded, the lower precipitate and part of the supernatant were resuspended, the resuspension was extracted 3 times with an equal volume of ethyl acetate, the extracts were combined, the mixture was spun on a rotary evaporator until crystals appeared, the crystals were reconstituted with methanol and removed by filtration through an organic membrane of 0.22 μm, the ursodeoxycholic acid, lithocholic acid content was analyzed by high performance liquid chromatography of example 2, and the conversion of LCA to UDCA was 42%.
Claims (10)
1. The fusarium equiseti is characterized in that the fusarium equiseti is fusarium equiseti (Fusarium equiseti) HG18, and the preservation number is CCTCC M2023160.
2. A method of using the fusarium equiseti hydroxy fossil cholic acid of claim 1, comprising the steps of:
adding a liquid culture containing Fusarium equisetosum into a fermentation medium, adding lithocholic acid, and culturing to obtain a fermentation broth containing ursodeoxycholic acid;
the Fusarium equisetum is Fusarium equisetum (Fusarium equiseti) HG18 CCTCC M2023160.
3. The method of claim 2, wherein the fermentation medium is composed of: 20-30g/L of carbon source, 10-30g/L of nitrogen source, 1-5g/L of yeast powder and KH 2 PO 4 1-5g/L,MgSO 4 ·7H 2 O 0.1-1g/L,FeSO 4 ·7H 2 0.01-0.5g/L O, 0-0.1M metal ion compound; adjusting pH of the culture medium to 5.5-10 before sterilization, and sterilizing at 121+ -5deg.C under high pressure steam for 20+ -5 min.
4. The method according to claim 2, characterized in that the composition of the fermentation medium is as follows: 20g/L of carbon source, 15g/L of nitrogen source, 1g/L of yeast powder and KH 2 PO 4 3g/L,MgSO 4 ·7H 2 O 0.5g/L,FeSO 4 ·7H 2 O0.02 g/L; the pH of the medium was adjusted to 7.5 before sterilization.
5. The method according to claim 2, wherein the carbon source is one or more of glucose, lactose, sucrose, soluble starch, dextrin;
the nitrogen source is NH 4 One or more of Cl, corn steep liquor dry powder, wall-broken dry yeast, peptone, yeast powder and L-asparagine;
the metal ion compound is NaCl, caCl 2 、MgCl 2 、CuCl 2 、ZnCl 2 、NH 4 One or more of Cl and KCl.
6. The method according to claim 2, wherein the inoculum size of fusarium equiseti is 10-30% (v/v), and the final concentration of lithocholic acid in the fermentation medium is 2g/L; the culture conditions were as follows: the culture temperature is 25-30 ℃, and the fermentation culture is carried out for 96-144h at the rotating speed of 120-220 rpm.
7. The method according to claim 2, wherein the liquid culture containing fusarium equiseti is obtained by: 100 mu L of fusarium equiseti spore frozen stock solution is coated on a PDA solid culture medium, cultured for 5-7 days at 25-40 ℃, resuspended by 0.2% Tween 80 water to obtain spore suspension, and inoculated into a seed culture medium for culture, thus obtaining the fusarium equiseti-containing liquid culture.
8. The method of claim 7, wherein the concentration of spores in the spore suspension is (1-1.7). Times.10 6 The spore/mL is inoculated into 50mL of seed culture medium at the inoculation proportion of 1mL spore suspension, and the culture condition is that the temperature is 25-30 ℃ and the culture is 120-220rpm for 12-72h.
9. The method of claim 7, wherein the seed culture medium comprises the following components in percentage: 20g/L of carbon source, 15g/L of nitrogen source, 1g/L of yeast powder and KH 2 PO 4 3g/L,MgSO 4 ·7H 2 O0.5 g/L; natural pH, sterilizing at 121deg.C under high pressure steam for 20min;
the PDA culture medium comprises the following components in percentage by weight: 200g/L potato; glucose 20g/L; 20g/L of agar powder; naturally pH, and sterilizing at 121deg.C under high pressure steam for 20min.
10. The method of claim 9, wherein the carbon source of the seed medium is one or more of glucose, lactose, sucrose, soluble starch, dextrin;
the nitrogen source of the seed culture medium is NH 4 One or more of Cl, corn steep liquor dry powder, wall-broken dry yeast, peptone, yeast powder and L-asparagine;
the incubation time of the spore suspension in the seed medium was 36 hours.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310241202.4A CN116410871A (en) | 2023-03-13 | 2023-03-13 | Fusarium equisetum and method for hydroxylating cholic acid by using same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310241202.4A CN116410871A (en) | 2023-03-13 | 2023-03-13 | Fusarium equisetum and method for hydroxylating cholic acid by using same |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116410871A true CN116410871A (en) | 2023-07-11 |
Family
ID=87055731
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310241202.4A Pending CN116410871A (en) | 2023-03-13 | 2023-03-13 | Fusarium equisetum and method for hydroxylating cholic acid by using same |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116410871A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117025709A (en) * | 2023-07-31 | 2023-11-10 | 华南理工大学 | Application of cytochrome P450 enzyme and cytochrome P450 reductase combined in synthesis of ursodeoxycholic acid |
-
2023
- 2023-03-13 CN CN202310241202.4A patent/CN116410871A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117025709A (en) * | 2023-07-31 | 2023-11-10 | 华南理工大学 | Application of cytochrome P450 enzyme and cytochrome P450 reductase combined in synthesis of ursodeoxycholic acid |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11149048B2 (en) | High-purity D-psicose preparation method | |
EP3098303B1 (en) | Microbial fermentation methods and compositions | |
CN103497911B (en) | Application of Chryseobacterium sp. and carbonyl reductase thereof in production of aprepitant chiral intermediate | |
CN103898004B (en) | The method of Selective medium and fermentative production U-32070E thereof | |
CN106635934B (en) | Thermophilic lactobacillus and corn soaking method by artificially adding thermophilic lactobacillus | |
CN116410871A (en) | Fusarium equisetum and method for hydroxylating cholic acid by using same | |
CN107189949B (en) | Rhizopus oryzae LJH3 and application thereof in preparation of genistein by biotransformation of sophoricoside | |
WO2008145071A1 (en) | A method of fermentation production of coenzyme q10 | |
CN108823110B (en) | Strain for producing griseofulvin and application thereof | |
CN108841889B (en) | Method for producing griseofulvin serving as major component of tranexamycin by microbial fermentation | |
CN117229979B (en) | Extended microbubble strain for producing algin lyase and application thereof | |
CN111909881B (en) | Bacillus pumilus capable of producing feruloyl esterase and application thereof | |
CN1165610C (en) | Aspergillus niger and its microbial conversion process of producing vanillic acid and vanillic aldehyde | |
US20150125915A1 (en) | Method for Producing Lactic Acid | |
CN113755353B (en) | Saccharomyces cerevisiae for preparing NMN | |
CN112725205B (en) | Saccharomyces strain and screening method and application thereof | |
CN112094762B (en) | Corynebacteria vinifera strain and application thereof | |
CN110358687B (en) | Gibberellin for producing D-pantolactone hydrolase and application and fermentation method thereof | |
CN112725238B (en) | Streptomyces toxytricini strain for producing lipstatin through fermentation and application thereof | |
CN110591968A (en) | Method for producing phospholipase D from streptomyces cinnamomi and method for measuring activity of phospholipase D | |
CN101182481A (en) | Bordetellasp and uses for preparations of cholesterol oxidase and cholest-4-en-3-ol thereof | |
CN101134940B (en) | Fermentation production method for Chinese caterpillar fungus fungus-bat moth hirsutella sinensis | |
CN104419646A (en) | Penicillium simplicissimum capable of biologically synthesizing 1,2-testololactone and synthesis method of 1,2-testololactone | |
CN116836883B (en) | Clostridium thermochromaticum strain and application thereof | |
CN114395494B (en) | Saberlin Dener yeast T52 and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |